The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma

Autor:	Nabil K. Bissada, Richard B. Bourne, W. Lamar Weems, Mark S. Soloway, William R. Turner, Donald Harris, James Nickson, Njoek Le, Roy P. Finney, John R. Canning, Carl A. Olsson, Kent Woodward, Gordon D. Deraps, Joseph A. Libnoch, Vincent Ciavarra, Ralph Jensen, Karl Eurenius, Samuel S. Clark, David F. Paulson, Roger W. Byhardt, Bernard Hickman, Wendell F. Rosse, Robert C. Hartmann, Bernard Roswit, Alptekin Ucmakli, Stefano S. Stefani, Keene M. Wallace, Waun Ki Hong
Rok vydání:	1979
Předmět:	Male medicine.medical_specialty Skeletal survey Urology Biopsy Physical examination Disease Adenocarcinoma Bone and Bones medicine Methods Humans Stage (cooking) Radionuclide Imaging Lymph node Neoplasm Staging medicine.diagnostic_test Prostatic adenocarcinoma business.industry Lymphography Prostatic Neoplasms Surgery Bone scanning Dissection medicine.anatomical_structure Radiology Lymph Nodes business
Zdroj:	The Journal of urology. 121(3)
ISSN:	0022-5347
Popis:	We studied 454 patients with prostatic adenocarcinoma who were assigned a preliminary clinical stage on the basis of serum acid phosphatase, routine bone survey and physical examination. Subsequently, they were assigned a final clinical stage after radioisotopic bone scanning, lymphangiography and staging pelvic lymph node dissection. Only 53, 54, 57 and 26 per cent, respectively, of patients initially assigned the preliminary clinical stage of IB, II, III or IVA remained at that stage after the additional studies.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4cc3a189a9bcd2c8566dc5282339a18 https://pubmed.ncbi.nlm.nih.gov/430622 Zobrazit plný text záznamu